Azitra Reports Q3 GAAP EPS of -$0.29, Missing Estimates by $0.04
Azitra (AZTR) reported third-quarter financial results for the period ending September 30, 2026, revealing a GAAP earnings per share (EPS) of -$0.29. This figure represents a miss of $0.04 relative to analyst expectations. The company's Research and Development (R&D) expenses saw a slight increase during the quarter, totaling $1.3 million compared to $1.2 million in the same period the previous year. The results reflect ongoing investment in the company's clinical pipeline.
Tickers: $AZTR
Topics: GAAP EPS quarterly earnings R&D expenses